Hung Yi Chen
Public Communications Contact bij StemCyte, Inc.
Oorsprong van het eerstegraads netwerk van Hung Yi Chen
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
StemCyte, Inc.
 StemCyte, Inc. BiotechnologyHealth Technology StemCyte, Inc. operates as a biotechnology company that collects, banks and distributes cord blood stem cell transfusion units. It focuses on stem cell transplantation, therapy, applications, diagnostics, and genomic research. The firm uses insulated containers to keep your baby's cord blood cool throughout transport. The company was founded by Denis Rodgerson and Robert Chow in 1997 and is headquartered in Covina, CA.
13
| Holding Company | Biotechnology | 13 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Hung Yi Chen via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| National Taiwan University | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
Sycamore Ventures Pte Ltd.
 Sycamore Ventures Pte Ltd. Investment ManagersFinance Sycamore Ventures Pte Ltd. (Sycamore Ventures) is a private equity and venture capital subsidiary of Sycamore Management Corp., founded in 1995 by Mr. Kilin To, Mr. Peter Gerry, and the late Mr. John Whitman. The firm is headquartered in Princeton, New Jersey. | Investment Managers | Private Equity Investor Private Equity Investor | |
| National Defense Medical Center | College/University | Undergraduate Degree Doctorate Degree | |
Epitomics, Inc.
 Epitomics, Inc. Pharmaceuticals: MajorHealth Technology Epitomics, Inc. an emerging biotechnology company, is dedicated to developing their breakthrough monoclonal antibody technology (RabMAb®) for research, diagnostics and therapeutics. The Company has utilized a unique and proprietary RabMAb technology invented by scientists at Loyola University of Chicago and the University of California at San Francisco. This enabling platform produces high quality antibodies that have the potetial to be used in the broad areas of research, diagnostics and therapeutics. Compared to currently available monoclonal antibody technology, such as mouse hybridomas, the company's proprietary technology can generate RabMAbs more efficiently and with superior binding affinity and bioactivity in a wide variety of biological assays. The high throughput and robust nature of the technology allows for the simultaneous discovery of disease targets and potential therapeutic antibodies in the same experiments, significantly shortening the drug discovery and development cycle. The company aims to become the largest provider of monoclonal antibody technology through developing and commercializing their RabMAb technology and products in research, diagnostics, and therapeutics. The firm is headquartered in Burlingame, California and operates a wholly owned subsidiary in Hangzhou, the People's Republic of China. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Stemcyte Taiwan
 Stemcyte Taiwan Medical/Nursing ServicesHealth Services Stemcyte Taiwan, founded in 2000, is a private company based in New Taipei City, Taiwan that specializes in umbilical cord blood banking. Stemcyte Taiwan has been recognized by over 350 medical centers worldwide and has helped with over 2,500 cord blood transplants. The Taiwanese company has a large public cord blood bank and exclusive patent technology for red blood cell separation. Stemcyte Taiwan has received international accreditations from AABB, FACT, NMDP, WMDA, and FDA, providing customers with secure and transparent contracts. | Medical/Nursing Services | Chairman Director/Board Member | |
| FOUNTAIN BIOPHARMA INC | Pharmaceuticals: Other | Chief Executive Officer Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Sycamore Management Corp.
 Sycamore Management Corp. Investment ManagersFinance Sycamore Management Corp. (dba Sycamore Ventures) is an independent asset management firm headquartered in Princeton, New Jersey. The firm was founded in 1995 by Joseph Cho and Peter Gerry. Sycamore Ventures manages investment portfolios for individual and institutional clients. | Investment Managers | Portfolio Manager-Equities Portfolio Manager-Equities | |
| SUNWAY BIOTECH CO., LTD. | Biotechnology | Chairman Director/Board Member | |
| Aulisa Medical Technologies, Inc. | Director/Board Member | ||
| DDM Social Welfare & Charity Foundation | Director/Board Member | ||
| ASIA CEMENT CORPORATION | Construction Materials | Director/Board Member | |
| CHINA AIRLINES, LTD. | Airlines | Director/Board Member | |
| VANGUARD INTERNATIONAL SEMICONDUCTOR CORPORATION | Semiconductors | Director/Board Member | |
| CHUNG HWA PULP CORPORATION | Pulp & Paper | Director/Board Member | |
Bank SinoPac Co., Ltd.
 Bank SinoPac Co., Ltd. Regional BanksFinance Bank SinoPac Co. Ltd. provides commercial banking services. The firm's services include deposits, personal banking, electronic financial transactions, short term and long term credits. The company is located in Taipei, Taiwan. | Regional Banks | Director/Board Member | |
| SINOPAC FINANCIAL HOLDINGS COMPANY LIMITED | Regional Banks | Director/Board Member | |
| MIRLE AUTOMATION CORPORATION | Computer Peripherals | Director/Board Member | |
Crown Bioscience, Inc.
 Crown Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Crown Bioscience, Inc. provides biomedical outsourcing solutions. It provides syngeneic and xenograft tumor models and custom model development and drug testing. The firm produces antibodies for therapeutic, diagnostic and theranostic applications. It also offers preclinical and drug development for anti-cancers therapeutics. The company was founded by Dr. Yiyou Chen, Dr. Yue Alexander Wu, Dr. William Pan and Dr. Faming Zhang in 2006 and is headquartered in Santa Clara, CA. | Miscellaneous Commercial Services | Director/Board Member | |
| TURG POIN | Pharmaceuticals: Major | Director/Board Member | |
| FORESEE PHARMACEUTICALS CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
GenePharm Biotech Corp.
 GenePharm Biotech Corp. Pharmaceuticals: MajorHealth Technology Part of Munir Sukhtian Pharmaceuticals, GenePharm Biotech Corp. develops and commercializes preventive and curative therapeutics for skin-related problems. The company is based in Xizhi District, Taiwan. | Pharmaceuticals: Major | Chairman | |
| CHINA STEEL CORPORATION | Steel | Director/Board Member | |
| T N Soong & Co. | Chairman | ||
Applied BioCode, Inc.
 Applied BioCode, Inc. Electronic Equipment/InstrumentsElectronic Technology Part of Applied BioCode Corp., Applied BioCode, Inc. is a diagnostic testing company that designs, develops, and commercializes multiplex testing products. The company is based in Santa Fe Springs, CA. Applied BioCode offers a range of diagnostic assays, including the BioCode SARS-CoV-2 assay, the BioCode Respiratory Pathogen Panel, and the BioCode Gastrointestinal Pathogen Panel. The company's technology combines "digital barcodes" with immuno- and molecular chemistry to create a new, bio-inspired Barcoded Magnetic Beads (BMB) technology. The micro BMBs are about the diameter of a human hair and are the ideal choice for cost-effective high throughput syndromic panels. The company was founded in 2008 by Winston Z. Ho, and Christopher M. Bernard has been the CEO of the company since 2022. | Electronic Equipment/Instruments | Chairman | |
Blossomhill Therapeutics, Inc.
 Blossomhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Blossomhill Therapeutics, Inc. is a small molecule drug discovery and development company that focuses on unmet medical needs in oncology and autoimmune disorders. The company is based in San Diego, CA. Dr. Cui is the lead inventor of multiple oncology medicines and clinical compounds, including crizotinib, lorlatinib, repotrectinib (TPX-0005), TPX-0022, TPX-0046, and TPX-0131. The company was founded by J. Jean Cui, Ph.D., a renowned drug design and development scientist, and Y. Peter Li, Ph.D., M.B.A., a biotech veteran. Jing Rong Cui has been the CEO since incorporation. | Pharmaceuticals: Major | Director/Board Member | |
RevMAb Biosciences, Inc.
 RevMAb Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services RevMAb Biosciences, Inc. operates as a biotechnology company. It focuses on the development of monoclonal antibodies using a revolutionary technology that does not require cell fusion and hybridoma generation. The company is headquartered in South San Francisco, CA. | Miscellaneous Commercial Services | Chairman | |
| PharmTak, Inc. | Director/Board Member | ||
| National Cheng Kung University | College/University | Undergraduate Degree | |
| MOTECH INDUSTRIES INC. | Semiconductors | Director/Board Member | |
| TAIWAN HIGH SPEED RAIL CORPORATION | Other Transportation | Director/Board Member | |
| President Life Sciences Co., Ltd. | Corporate Officer/Principal | ||
President Futures Corp.
 President Futures Corp. Investment Banks/BrokersFinance Part of Uni-President Enterprises Corp., President Futures Corp. is a financial company based in Taipei, Taiwan. The Taiwanese company specializes in providing investors with a tool to hedge against interest rate risks and to capitalize on potential profits from interest rate changes through the use of financial derivatives, specifically the US Treasury bond futures. The company offers a comprehensive guide on the basic concepts, operational principles, and factors affecting the price of US Treasury bond futures. The guide also includes information on the types of US Treasury bonds, the contract specifications of US Treasury bond futures, and how to calculate profits and losses. The company's services are mainly targeted towards institutional investors who hold large amounts of bonds and require flexible trading options. | Investment Banks/Brokers | Chairman | |
| PRESIDENT SECURITIES CORPORATION | Investment Banks/Brokers | Corporate Officer/Principal | |
| SINEW PHARMA INC. | Biotechnology | Director/Board Member | |
| MICROBIO CO., LTD. | Pharmaceuticals: Other | Director/Board Member | |
| National Chung Hsing University | College/University | Undergraduate Degree | |
| EVER SUPREME BIO TECHNOLOGY CO., LTD | Biotechnology | Chief Tech/Sci/R&D Officer | |
| BIONIME CORPORATION | Medical Specialties | Director/Board Member | |
| SUNNY PHARMTECH INC. | Medical/Nursing Services | Director/Board Member | |
Tetanti Agribiotech, Inc.
 Tetanti Agribiotech, Inc. Medical SpecialtiesHealth Technology Tetanti Agribiotech, Inc. manufactures enzyme processing equipment, and provides biotechnology services. The company was founded by Qiu Zhong Yang on June 25, 2018 and is headquartered in Taichung, China. | Medical Specialties | Director/Board Member | |
| University of Massachusetts | College/University | Graduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree | |
| T N Soong Foundation | Director/Board Member | ||
| Queensland University of Technology | College/University | Graduate Degree | |
| National Chengchi University | College/University | Undergraduate Degree | |
| HON HAI PRECISION INDUSTRY CO., LTD. | Computer Peripherals | Director/Board Member | |
| University of Illinois | College/University | Graduate Degree |
Statistieken
Internationaal
| Taiwan | 36 |
| Verenigde Staten | 15 |
| Australië | 2 |
Sectoraal
| Health Technology | 14 |
| Consumer Services | 11 |
| Finance | 7 |
| Electronic Technology | 7 |
| Health Services | 3 |
Operationeel
| Director/Board Member | 63 |
| Corporate Officer/Principal | 25 |
| Chairman | 16 |
| Independent Dir/Board Member | 12 |
| Undergraduate Degree | 11 |
Sterkste connecties
| Insiders | |
|---|---|
| George Lee | 26 |
| Ching Yi Wang | 24 |
| Jimmy C. Lu | 19 |
| John R. Whitman | 16 |
| Kenneth Giacin | 11 |
| Jonas Wang | 10 |
| Mei An Liu | 9 |
| Li Chun Han | 7 |
| Cheng Yue Liu | 3 |
| Yue Chuan Lv | 3 |
| Wei Cheng Hsu | 3 |
| Chun Chun Tang | 2 |
| John Zaia | 2 |
- Beurs
- Insiders
- Hung Yi Chen
- Bedrijfsconnecties
